Novo Nordisk A/S (NONOF)
37.39
+0.06
(+0.15%)
USD |
OTCM |
Oct 06, 16:00
Novo Nordisk Price to Book Value : 4.884 for Oct. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 4.884 |
| October 05, 2026 | 4.877 |
| October 02, 2026 | 4.834 |
| October 01, 2026 | 4.882 |
| September 30, 2026 | 4.983 |
| September 29, 2026 | 5.008 |
| September 28, 2026 | 5.013 |
| September 25, 2026 | 5.049 |
| September 24, 2026 | 5.016 |
| September 23, 2026 | 4.996 |
| September 22, 2026 | 5.136 |
| September 21, 2026 | 5.214 |
| September 18, 2026 | 5.566 |
| September 17, 2026 | 5.486 |
| September 16, 2026 | 5.428 |
| September 15, 2026 | 5.540 |
| September 14, 2026 | 5.704 |
| September 11, 2026 | 5.641 |
| September 10, 2026 | 5.766 |
| September 09, 2026 | 5.808 |
| September 08, 2026 | 5.936 |
| September 04, 2026 | 6.048 |
| September 03, 2026 | 6.074 |
| September 02, 2026 | 6.120 |
| September 01, 2026 | 5.924 |
| Date | Value |
|---|---|
| August 31, 2026 | 5.910 |
| August 28, 2026 | 5.880 |
| August 27, 2026 | 6.029 |
| August 26, 2026 | 6.19 |
| August 25, 2026 | 6.286 |
| August 24, 2026 | 6.139 |
| August 21, 2026 | 6.114 |
| August 20, 2026 | 6.052 |
| August 19, 2026 | 5.930 |
| August 18, 2026 | 5.867 |
| August 17, 2026 | 5.892 |
| August 14, 2026 | 5.896 |
| August 13, 2026 | 5.981 |
| August 12, 2026 | 5.970 |
| August 11, 2026 | 6.127 |
| August 10, 2026 | 6.174 |
| August 07, 2026 | 6.149 |
| August 06, 2026 | 5.920 |
| August 05, 2026 | 5.852 |
| August 04, 2026 | 5.812 |
| August 03, 2026 | 5.986 |
| July 31, 2026 | 6.009 |
| July 30, 2026 | 6.505 |
| July 29, 2026 | 6.599 |
| July 28, 2026 | 6.531 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 32.17 |
| ALK-Abello A/S | 6.478 |
| H. Lundbeck A/S | 1.545 |
| AstraZeneca PLC | 10.39 |
| Dr. Reddy's Laboratories Ltd. | 2.568 |
Price to Book Value Related Metrics
| PE Ratio | 9.139 |
| PS Ratio | 3.231 |
| PEG Ratio | 0.7253 |
| Price to Free Cash Flow | 22.56 |
| Price | 37.39 |
| Earnings Yield | 10.94% |
| Market Cap | 165.31B |
| PEGY Ratio | 0.5247 |
| Operating PE Ratio | 7.120 |
| Normalized PE Ratio | 8.784 |